28996 |
HOMEODOMAIN INTERACTING PROTEIN KINASE 2 |
HIPK2 |
PRO0593 |
606868 |
14402 |
ENSG00000064393 |
OTTHUMG00000157704 |
Q9H2X6 |
HOMEODOMAIN-INTERACTING PROTEIN KINASE 2 |
HIPK2_HUMAN |
HOMEODOMAIN-INTERACTING PROTEIN KINASE 2 (EC 2.7.1.37) (HHIPK2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q9H2X6] |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.1 |
Interpro Type | Domain |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
Interpro Acc | IPR002290 |
Human Readable Name | DRUGGABLE GENOME |
Human Readable Name | KINASE |
Uniprot Status | Swiss-Prot |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Gene Biotype | PROTEIN_CODING |
TUMOR SUPPRESSOR |
KINASE |
SERINE THREONINE KINASE |
TYROSINE KINASE |
DRUGGABLE GENOME |
TRANSCRIPTION FACTOR |
n/a |
Trial Name | Vadimezan |
Novel drug target | Novel Target |
HIPK2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
HIPK2 | Uniprot Gene Name |
Q9H2X6 | Uniprot Accession |
HOMEODOMAIN-INTERACTING PROTEIN KINASE 2 | Uniprot Protein Name |
Interpro Type | Domain |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
KINASE, DRUGGABLE GENOME |
HIPK2 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.1 |
ENSG00000064393 | Ensembl Gene Id |
HIPK2 | Display Id |
HOMEODOMAIN-INTERACTING PROTEIN KINASE 2 (EC 2.7.1.37) (HHIPK2). [SOURCE:UNIPROT/SWISSPROT;ACC:Q9H2X6] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
ENSG00000064393 | Gene Symbol |
HIPK2 | Ensembl Id |
DRUGGABLE GENOME |
28996 | Gene ID |
PRO0593 | dGene Synonym |
KINASE, SERINE THREONINE KINASE |
Homeodomain-interacting protein kinase 2 | Gene Name |
Q9H2X6 | UniProt ID |
KINASE, TRANSCRIPTION FACTOR |
TUMOR SUPPRESSOR, SERINE THREONINE KINASE, TYROSINE KINASE |